(Q32146508)

6 July 2017

title

Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa (English)

1 reference

dexamethasone suppression test

6 July 2017

1 reference

0 references

0 references

1 reference

1 reference

Neudeck P

1

1 reference

6 July 2017

Jacoby GE

series ordinal

2

1 reference

6 July 2017

Florin I

series ordinal

3

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

6 July 2017

published in

Physiology & Behavior

1 reference

6 July 2017

volume

72

1 reference

6 July 2017

issue

1-2

1 reference

6 July 2017

page(s)

93-98

1 reference

Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia.

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The dexamethasone suppression test in healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Clinical utility of the dexamethasone suppression test assessed by plasma and salivary cortisol determinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Effects of weight loss on the dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The dexamethasone suppression test in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Use of saliva cortisol in the dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Comparisons of plasma and salivary cortisol determinations for the diagnostic efficacy of the dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Weight loss causes neuroendocrine disturbances: experimental study in healthy starving subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The dexamethasone suppression test in bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Neuroendocrine abnormalities in bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The effect of bingeing and vomiting on hormonal secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The effect of weight loss and inappropriate plasma dexamethasone levels on the DST.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Dexamethasone suppression test and plasma dexamethasone levels in bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Hypothalamic serotonin in control of eating behavior, meal size, and body weight

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Role of leptin in hypothalamic-pituitary function

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Leptin indirectly affects estrous cycles by increasing metabolic fuel oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The measurement of hormones in saliva: possibilities and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

The Eating Attitudes Test: an index of the symptoms of anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2800%2900387-5

7 January 2021

10.1016/S0031-9384(00)00387-5

Identifiers

DOI

1 reference

6 July 2017

1 reference